Essentials of cardio-oncology

Cardio-oncology is a subspecialty that provides cardiac care for patients with cancer. Newer oncological agents have not only increased survivorship, but also sprouted novel cardiovascular toxicity (CVT) involving any component of the cardiovascular system, albeit with some preferential targets. Patients with cancer should undergo a baseline cardiovascular risk assessment and have individualised surveillance planned during cancer therapy and post treatment. The early diagnosis of CVT, by clinical history and examination along with imaging and laboratory analysis, is paramount. Management includes cardioprotective strategies and multidisciplinary decision-making regarding the riskbenefit ratio of oncological treatment based on CVT.

Automated summary

Cardio-oncology is a subspecialty that provides cardiac care for cancer patients. Cardiovascular toxicity (CVT) caused by newer oncological agents has emerged as a concern, emphasizing the need for baseline assessment and individualized surveillance during and after cancer therapy. Early diagnosis and management strategies are crucial.